Butantan says he will not meet the deadline for delivery of doses of CoronaVac – Prime Time Zone

4

Institute denied delay and stated that the units will be shipped within the period stipulated by the contract; Ministry of Health excluded the use of the vaccine for the application of the third dose

ADRIANA TOFFETTI/A7 PRESS/ESTADÃO CONTENT – 12/12/2020Contract between the Institute and the Ministry of Health provides for completion of delivery by the end of September

the president of Butantan Institute, Dimas Caves, announced that it will not be able to complete until this Tuesday, 31, the delivery of the 54 million doses of the vaccine CoronaVac against Covid-19 to the federal government. The statement was given this Monday morning, 30, during a press conference held in the delivery of 10 million doses of the immunizing agent. “We won’t deliver the 54 million doses until tomorrow. We are rescheduling deliveries due to two facts. The first fact was the manifestation of the Ministry, which excluded the use of the vaccine for the application of the third dose. So, this changes the schedule a little bit. We are rescheduling because we have other contracts to be serviced, other states, other countries, so we are rescheduling, we are not going to deliver the 54 million,” said Covas. Wanted by Young pan, Butantan clarified that the postponement will not be a delay, since the deadline for completion of the delivery is the end of September. However, the agency confirmed the postponement planned by the government of the State of São Paulo, which intended to conclude the process this Tuesday, 31.

Last week, the Ministry of Health announced the application of a third dose of the vaccine against Covid-19 in elderly people over 70 years and immunosuppressed people. The forecast is for the procedure to start in the second half of September. However, the paste stated that the application should be made with doses of Pfizer and, if not possible, with the AstraZeneca Where Janssen. CoronaVac was not mentioned in the decision and should not be used. The decision was taken after a joint meeting between the Technical Advisory Chamber on Immunization Covid-19 of the Ministry of Health (CETAI), the National Council of Health Secretaries (Conass) and the National Council of Municipal Health Secretariats (Conasems).